Adamant Biomedical Investment Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 3

Adamant Biomedical Investment General Information

Description

Provider of healthcare asset management services. The company provides healthcare research & portfolio management services.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Freischutzgasse 3
  • 8004 Zurich
  • Switzerland
Primary Industry
Other Financial Services
Acquirer
Corporate Office
  • Freischutzgasse 3
  • 8004 Zurich
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adamant Biomedical Investment Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Adamant Biomedical Investment‘s full profile, request access.

Request a free trial

Adamant Biomedical Investment Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adamant Biomedical Investment Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Adamant Biomedical Investment‘s full profile, request access.

Request a free trial

Adamant Biomedical Investment Investments (3)

Adamant Biomedical Investment’s most recent deal was a Later Stage VC with Veloxis Pharmaceuticals for . The deal was made on 17-May-2005.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Veloxis Pharmaceuticals 17-May-2005 Later Stage VC Drug Discovery
Affectis Pharmaceuticals 13-Apr-2005 Early Stage VC Drug Discovery
Cytos Biotechnology 23-Jan-2002 Later Stage VC Drug Discovery
To view Adamant Biomedical Investment’s complete investments history, request access »

Adamant Biomedical Investment Exits (3)

Adamant Biomedical Investment’s most recent exit was on 17-May-2005 from Veloxis Pharmaceuticals. The exit was categorized as with 7 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Veloxis Pharmaceuticals 17-May-2005 Completed
  • 7 buyers
Affectis Pharmaceuticals 13-Apr-2005 Completed
  • 6 buyers
Cytos Biotechnology 23-Jan-2002 Later Stage VC Completed
  • 6 buyers
To view Adamant Biomedical Investment’s complete exits history, request access »

Adamant Biomedical Investment FAQs

  • When was Adamant Biomedical Investment founded?

    Adamant Biomedical Investment was founded in 2000.

  • Where is Adamant Biomedical Investment headquartered?

    Adamant Biomedical Investment is headquartered in Zurich, Switzerland.

  • What is the size of Adamant Biomedical Investment?

    Adamant Biomedical Investment has 11 total employees.

  • What industry is Adamant Biomedical Investment in?

    Adamant Biomedical Investment’s primary industry is Other Financial Services.

  • Is Adamant Biomedical Investment a private or public company?

    Adamant Biomedical Investment is a Private company.

  • What is the current valuation of Adamant Biomedical Investment?

    The current valuation of Adamant Biomedical Investment is .

  • What is Adamant Biomedical Investment’s current revenue?

    The current revenue for Adamant Biomedical Investment is .

  • Who are Adamant Biomedical Investment’s investors?

    Zürcher Kantonalbank has invested in Adamant Biomedical Investment.

  • When was Adamant Biomedical Investment acquired?

    Adamant Biomedical Investment was acquired on 30-Sep-2014.

  • Who acquired Adamant Biomedical Investment?

    Adamant Biomedical Investment was acquired by Bellevue Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process